Wishing all our customers a joyful holiday season and a fantastic New Year!
FOR IMMEDIATE RELEASE CONTACT: Daina Basile Kovak-Likly Communications203-762-8833, dbasile@klcpr.com YARAL PHARMA LAUNCHES LIDOCAINE PATCH 5% Expands its Line of Non-Opioid Prescription Medications PARSIPPANY, NJ – September 1, 2023 – Yaral Pharma Inc., (Yaral Pharma), the United States generics subsidiary of IBSA (Institut Biochimique SA), one of the world’s leaders in transdermal and topical patch technology, …
FOR IMMEDIATE RELEASE CONTACT: Daina Basile Kovak-Likly Communications203-762-8833, dbasile@klcpr.com YARAL PHARMA PARTNERS WITH EVERSANA TO SUPPORT THE COMMERCIALIZATION OF ITS EXPANDING GENERICS PORTFOLIO Partnership Supports Commitment to Providing High-Quality Products, Supply Chain Continuity, and Exceptional Customer Service PARSIPPANY, NJ – May 22, 2023 – YARAL Pharma Inc., (YARAL Pharma) the United States generics subsidiary of …
FOR IMMEDIATE RELEASE CONTACT: Daina Basile Kovak-Likly Communications203-762-8833, dbasile@klcpr.com YARAL PHARMA LAUNCHES DICLOFENAC EPOLAMINE TOPICAL SYSTEM 1.3% Authorized Generic of Flector® Now Available Parsippany, NJ – January 3, 2023 – YARAL Pharma Inc., the US generics subsidiary of IBSA, a long-standing, multinational pharmaceutical company headquartered in Lugano, Switzerland today announced the launch of diclofenac epolamine …
YARAL Pharma Launches Diclofenac Epolamine Topical System 1.3% Read More »
YARAL Pharma Launches Diclofenac Epolamine Topical System 1.3% Jan 3, 2023 Authorized Generic of Flector® Now Available. Read the entire article at Pharmacy Times
FOR IMMEDIATE RELEASE Contact: Daina Basile Kovak-Likly Communications203-762-8833, dbasile@klcpr.com YARAL PHARMA LAUNCHES IN THE US US Subsidiary of IBSA to Commercialize Generic Portfolio Parsippany, NJ – December 12, 2022 – YARAL Pharma Inc., the US generics subsidiary of IBSA, a long-standing, multinational pharmaceutical company headquartered in Lugano, Switzerland, launched today with the mission of providing …